Analyst Viewpoint
Rise in prevalence of vascular diseases and increase in demand for minimally invasive surgeries are accelerating the drug eluting balloon industry growth. People prefer surgeries with less incisions and minimum blood loss due to faster recovery rate and minimum hospitalization period. These surgeries have high accuracy rate, as they are performed with laparoscopic imaging techniques and robotic surgical equipment. Thus, surge in demand for advanced treatments for cardiovascular diseases is boosting drug eluting balloon market dynamics.
High prevalence of peripheral artery disease among the elderly population is driving the demand for drug eluting balloons. Increase in investments in the healthcare sector and availability of reimbursement policies are fueling market progress. Leading market players are launching new products under government guidelines to ensure high accuracy and effectiveness of treatments.
Drug Eluting Balloon (DEB) is a type of angioplasty balloon that is coated with anti-proliferative drugs. These drugs are released into the vessel wall while the balloon is inflated, usually at nominal pressure with a specific minimal inflation time. This allows for the rapid delivery of the drug into the vessel wall.
Drug eluting balloon angioplasty is a medical procedure that is used to treat narrowed or blocked arteries. It involves the insertion of a catheter into an artery. The catheter is then used to inflate the balloon and deliver drug to the affected area.
Drug-coated balloon has the potential to prevent cell division, which limits the amount of restenosis or blockage re-growth after treatment.
Lutonix drug coated balloon is a catheter that has paclitaxel applied to the balloon. Drug-eluting balloons are commonly coated with drugs such as paclitaxel, a cytotoxic, and antineoplastic agent.
Vascular diseases affect blood vessels carrying nutrients and oxygen in the body. These diseases are caused due to plaque, which restricts the blood flow in veins and arteries. Major causes of these diseases are diabetes, blood infections, blood vessel spasms, blood vessel defects, and inflammation of arteries.
Drug eluting balloons are used to open up blocked veins and arteries. Aging population is more prone to vascular diseases. Thus, demand for drug eluting balloons is high in this segment.
Cardiovascular diseases affect blood flow in the body, creating blockages in veins. This may lead to heart attacks. People with obesity, diabetes, high cholesterol, and high blood pressure are more prone to cardiovascular diseases. Drug eluting balloons help reduce the risk of in-stent restenosis and late in-sent thrombosis. Targeted drug delivery in interventional cardiology plays an important role in the treatment of cardiovascular diseases.
Minimally invasive surgeries are procedures that have less number of incisions and smaller cuts. These procedures help reduce bleeding during surgeries and make them less painful. Minimally invasive surgeries ensure faster recovery rate due to fewer incisions and reduced hospitalization period.
Angioplasty surgeries are minimally invasive techniques that are preferred over open cardiovascular surgeries. Drug eluting stents in targeted drug delivery are used in angioplasty surgeries.
Increase in number of minimally invasive surgeries to treat cardiovascular diseases is bolstering the drug eluting balloon market revenue. Patients choose minimally invasive surgeries, as these often entail advanced laparoscopic procedures that are performed through a single incision.
Minimally invasive surgeries are image-guided and robotic surgeries that have high accuracy and faster recovery. Rise in demand for minimally invasive surgeries is driving the drug eluting balloon market demand.
Peripheral Artery Disease (PAD) is blockage or narrowing of blood vessels from heart to legs caused by the buildup of fatty plaque in atherosclerosis. Symptoms of PAD include painful cramping in the thighs, calf, and hip muscles; leg weakness or numbness; and coldness in lower legs or feet.
Peripheral drug eluting balloons are used to remove fatty plaque and increase blood circulation in the arteries. The peripheral drug eluting balloons segment is projected to hold leading share due to the increase in prevalence of PAD among people aged above 65. Lack of physical activity is one of the key factors that causes PAD among the aging population.
North America is likely to hold the largest drug eluting balloon market share during the forecast period. High diagnosis rates and easy availability of treatments for cardiovascular diseases are driving market statistics in the region.
Presence of developed healthcare infrastructure and rise in funding from government as well as public organizations are augmenting the demand for drug eluting balloons in North America. Availability of reimbursement policies for cardiovascular and chronic diseases is encouraging patients in the region to seek treatments. Furthermore, growth in prevalence of PAD and heart diseases is augmenting the drug eluting balloon market size in North America.
Asia Pacific is expected to register steady market growth in the near future owing to the increase in patient population in the region. Rise in demand for minimally invasive surgeries is steering drug eluting balloon market development in Asia Pacific.
Increase in prevalence of diabetes and obesity is one of the leading causes of cardiovascular diseases among the people in Asia Pacific. This is driving drug eluting balloon market demand in the region.
According to the World Health Organization 2023 report, approximately 77 million people aged above 18 years are suffering from diabetes in India. Around 25 million people are pre-diabetic and more than 50% of the people are unaware of their diabetic status.
Prominent market participants are implementing various growth strategies such as new product launches and innovation in existing product range. These strategies allow companies to enhance their product portfolio and increase their business reach.
Some of the leading companies operating in the industry are Bayer AG, Medtronic, B. Braun Melsungen AG, Cook Medical, Inc., Boston Scientific Corporation, Becton, Dickson and Company, EuroCor, Terumo Corporation, and Koninklijke Philips N.V.
These players have been summarized in the drug eluting balloon market report based on parameters such as company overview, financial overview, business segments, product portfolio, business strategies, and key developments.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 571.1 Mn |
| Market Forecast (Value) in 2031 | US$ 1.0 Bn |
| Growth Rate (CAGR) | 7.1% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Tons | US$ Mn/Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 571.1 Mn in 2022
It is projected to register a CAGR of 7.1% from 2023 to 2031
Increase in prevalence of vascular diseases and rise in demand for minimally invasive procedures
North America was the most lucrative region in 2022
Bayer AG, Medtronic, B. Braun Melsungen AG, Cook Medical, Inc., Boston Scientific Corporation, Becton, Dickson and Company, EuroCor, Terumo Corporation, Koninklijke Philips N.V, and others
1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Drug Eluting Balloon Market
4. Market Overview
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Drug Eluting Balloon Market Analysis and Forecast, 2023-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. COVID-19 Pandemic Impact on Industry
6. Drug Eluting Balloon Market Analysis and Forecast, by Product
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2023-2031
6.3.1. Coronary Drug Eluting Balloon
6.3.2. Peripheral Drug Eluting Balloon
6.3.3. Others
6.4. Market Attractiveness, by Product
7. Drug Eluting Balloon Market Analysis and Forecast, by Technology
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2023-2031
7.3.1. Paccocath
7.3.2. FreePac
7.3.3. TransPax
7.3.4. EnduraCoat
7.3.5. Others
7.4. Market Attractiveness, by Technology
8. Global Drug Eluting Balloon Market Analysis and Forecast, by End-user
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2023-2031
8.3.1. Hospitals and Ambulatory Surgery Centers
8.3.2. Cath Labs
8.3.3. Others
8.4. Market Attractiveness, by End-user
9. Global Drug Eluting Balloon Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2023-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region
10. North America Drug Eluting Balloon Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2023-2031
10.2.1. Coronary Drug Eluting Balloon
10.2.2. Peripheral Drug Eluting Balloon
10.2.3. Others
10.3. Market Attractiveness, by Product
10.4. Market Value Forecast, by Technology, 2023-2031
10.4.1. Paccocath
10.4.2. FreePac
10.4.3. TransPax
10.4.4. EnduraCoat
10.4.5. Others
10.5. Market Attractiveness, by Technology
10.6. Market Value Forecast, by End-user, 2023-2031
10.6.1. Hospitals and Ambulatory Surgery Centers
10.6.2. Cath Labs
10.6.3. Others
10.7. Market Attractiveness, by End-user
10.8. Market Value Forecast, by Country, 2023-2031
10.8.1. U.S.
10.8.2. Canada
10.9. Market Attractiveness Analysis
10.9.1. By Product
10.9.2. By Technology
10.9.3. By End-user
10.9.4. By Country
11. Europe Drug Eluting Balloon Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2023-2031
11.2.1. Coronary Drug Eluting Balloon
11.2.2. Peripheral Drug Eluting Balloon
11.2.3. Others
11.3. Market Attractiveness, by Product
11.4. Market Value Forecast, by Technology, 2023-2031
11.4.1. Paccocath
11.4.2. FreePac
11.4.3. TransPax
11.4.4. EnduraCoat
11.4.5. Others
11.5. Market Attractiveness, by Technology
11.6. Market Value Forecast, by End-user, 2023-2031
11.6.1. Hospitals and Ambulatory Surgery Centers
11.6.2. Cath Labs
11.6.3. Others
11.7. Market Attractiveness, by End-user
11.8. Market Value Forecast, by Country/Sub-region, 2023-2031
11.8.1. Germany
11.8.2. U.K.
11.8.3. France
11.8.4. Italy
11.8.5. Spain
11.8.6. Rest of Europe
11.9. Market Attractiveness Analysis
11.9.1. By Product
11.9.2. By Technology
11.9.3. By End-user
11.9.4. By Country/Sub-region
12. Asia Pacific Drug Eluting Balloon Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2023-2031
12.2.1. Coronary Drug Eluting Balloon
12.2.2. Peripheral Drug Eluting Balloon
12.2.3. Others
12.3. Market Attractiveness, by Product
12.4. Market Value Forecast, by Technology, 2023-2031
12.4.1. Paccocath
12.4.2. FreePac
12.4.3. TransPax
12.4.4. EnduraCoat
12.4.5. Others
12.5. Market Attractiveness, by Technology
12.6. Market Value Forecast, by End-user, 2023-2031
12.6.1. Hospitals and Ambulatory Surgery Centers
12.6.2. Cath Labs
12.6.3. Others
12.7. Market Attractiveness, by End-user
12.8. Market Value Forecast, by Country/Sub-region, 2023-2031
12.8.1. China
12.8.2. Japan
12.8.3. India
12.8.4. Australia & New Zealand
12.8.5. Rest of Asia Pacific
12.9. Market Attractiveness Analysis
12.9.1. By Product
12.9.2. By Technology
12.9.3. By End-user
12.9.4. By Country/Sub-region
13. Latin America Drug Eluting Balloon Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2023-2031
13.2.1. Coronary Drug Eluting Balloon
13.2.2. Peripheral Drug Eluting Balloon
13.2.3. Others
13.3. Market Attractiveness, by Product
13.4. Market Value Forecast, by Technology, 2023-2031
13.4.1. Paccocath
13.4.2. FreePac
13.4.3. TransPax
13.4.4. EnduraCoat
13.4.5. Others
13.5. Market Attractiveness, by Technology
13.6. Market Value Forecast, by End-user, 2023-2031
13.6.1. Hospitals and Ambulatory Surgery Centers
13.6.2. Cath Labs
13.6.3. Others
13.7. Market Attractiveness, by End-user
13.8. Market Value Forecast, by Country/Sub-region, 2023-2031
13.8.1. Brazil
13.8.2. Mexico
13.8.3. Rest of Latin America
13.9. Market Attractiveness Analysis
13.9.1. By Product
13.9.2. By Technology
13.9.3. By End-user
13.9.4. By Country/Sub-region
14. Middle East & Africa Drug Eluting Balloon Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2023-2031
14.2.1. Coronary Drug Eluting Balloon
14.2.2. Peripheral Drug Eluting Balloon
14.2.3. Others
14.3. Market Attractiveness, by Product
14.4. Market Value Forecast, by Technology, 2023-2031
14.4.1. Paccocath
14.4.2. FreePac
14.4.3. TransPax
14.4.4. EnduraCoat
14.4.5. Others
14.5. Market Attractiveness, by Technology
14.6. Market Value Forecast, by End-user, 2023-2031
14.6.1. Hospitals and Ambulatory Surgery Centers
14.6.2. Cath Labs
14.6.3. Others
14.7. Market Attractiveness, by End-user
14.8. Market Value Forecast, by Country/Sub-region, 2023-2031
14.8.1. GCC Countries
14.8.2. South Africa
14.8.3. Rest of Middle East & Africa
14.9. Market Attractiveness Analysis
14.9.1. By Product
14.9.2. By Technology
14.9.3. By End-user
14.9.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Bayer AG
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Medtronic
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. B. Braun Melsungen AG
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Cook Medical, Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Boston Scientific Corporation
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Becton, Dickson and Company
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. EuroCor
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Terumo Corporation
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Koninklijke Philips N.V.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
List of Tables
Table 01: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031
Table 02: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031
Table 03: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user, 2023-2031
Table 04: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Region, 2023-2031
Table 05: North America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Country, 2023-2031
Table 06: North America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031
Table 07: North America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031
Table 08: North America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user, 2023-2031
Table 09: Europe Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
Table 10: Europe Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031
Table 11: Europe Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031
Table 12: Europe Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user 2023-2031
Table 13: Asia Pacific Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
Table 14: Asia Pacific Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031
Table 15: Asia Pacific Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031
Table 16: Asia Pacific Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user, 2023-2031
Table 17: Latin America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
Table 18: Latin America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031
Table 19: Latin America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031
Table 20: Latin America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user 2023-2031
Table 21: Middle East & Africa Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
Table 22: Middle East & Africa Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031
Table 23: Middle East & Africa Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031
Table 24: Middle East & Africa Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user 2023-2031
List of Figures
Figure 01: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, 2023-2031
Figure 02: Global Drug Eluting Balloon Market Value Share, by Product, 2022
Figure 03: Global Drug Eluting Balloon Market Value Share, by Technology, 2022
Figure 04: Global Drug Eluting Balloon Market Value Share, by End-user, 2022
Figure 05: Global Drug Eluting Balloon Market Value Share Analysis, by Product, 2022 and 2031
Figure 06: Global Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031
Figure 07: Global Drug Eluting Balloon Market Value Share Analysis, by Technology, 2022 and 2031
Figure 08: Global Drug Eluting Balloon Market Attractiveness Analysis, by Technology, 2023-2031
Figure 09: Global Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031
Figure 10: Global Drug Eluting Balloon Market Attractiveness Analysis, by End-user 2023-2031
Figure 11: Global Drug Eluting Balloon Market Value Share Analysis, by Region, 2022 and 2031
Figure 12: Global Drug Eluting Balloon Market Attractiveness Analysis, by Region, 2023-2031
Figure 13: North America Drug Eluting Balloon Market Value (US$ Mn) Forecast, 2023-2031
Figure 14: North America Drug Eluting Balloon Market Value Share Analysis, by Country, 2022 and 2031
Figure 15: North America Drug Eluting Balloon Market Attractiveness Analysis, by Country, 2023-2031
Figure 16: North America Drug Eluting Balloon Market Value Share Analysis, by Product, 2022 and 2031
Figure 17: North America Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031
Figure 18: North America Drug Eluting Balloon Market Value Share Analysis, by Technology, 2022 and 2031
Figure 19: North America Drug Eluting Balloon Market Attractiveness Analysis, by Technology, 2023-2031
Figure 20: North America Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031
Figure 21: North America Drug Eluting Balloon Market Attractiveness Analysis, by End-user 2023-2031
Figure 22: Europe Drug Eluting Balloon Market Value (US$ Mn) Forecast, 2022-2031
Figure 23: Europe Drug Eluting Balloon Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 24: Europe Drug Eluting Balloon Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 25: Europe Drug Eluting Balloon Market Value Share Analysis, by Product, 2022 and 2031
Figure 26: Europe America Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031
Figure 27: Europe Drug Eluting Balloon Market Value Share Analysis, by Technology, 2022 and 2031
Figure 28: Europe Drug Eluting Balloon Market Attractiveness Analysis, by Technology, 2023-2031
Figure 29: Europe Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031
Figure 30: Europe Drug Eluting Balloon Market Attractiveness Analysis, by End-user 2023-2031
Figure 31: Asia Pacific Drug Eluting Balloon Market Value (US$ Mn) Forecast, 2023-2031
Figure 32: Asia Pacific Drug Eluting Balloon Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 33: Asia Pacific Drug Eluting Balloon Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 34: Asia Pacific Drug Eluting Balloon Market Value Share Analysis, by Product, 2022 and 2031
Figure 35: Asia Pacific America Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031
Figure 36: Asia Pacific Drug Eluting Balloon Market Value Share Analysis, by Technology, 2022 and 2031
Figure 37: Asia Pacific Drug Eluting Balloon Market Attractiveness Analysis, by Technology, 2023-2031
Figure 38: Asia Pacific Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031
Figure 39: Asia Pacific Drug Eluting Balloon Market Attractiveness Analysis, by End-user 2023-2031
Figure 40: Latin America Drug Eluting Balloon Market Value (US$ Mn) Forecast, 2022-2031
Figure 41: Latin America Drug Eluting Balloon Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 42: Latin America Drug Eluting Balloon Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 43: Latin America Drug Eluting Balloon Market Value Share Analysis, by Product, 2022 and 2031
Figure 44: Latin America Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031
Figure 45: Latin America Drug Eluting Balloon Market Value Share Analysis, by Technology, 2022 and 2031
Figure 46: Latin America Drug Eluting Balloon Market Attractiveness Analysis, by Technology, 2023-2031
Figure 47: Latin America Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031
Figure 48: Latin America Drug Eluting Balloon Market Attractiveness Analysis, by End-user, 2023-2031
Figure 49: Middle East & Africa Drug Eluting Balloon Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 50: Middle East & Africa Drug Eluting Balloon Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 51: Middle East & Africa America Drug Eluting Balloon Market Value Share Analysis, by Product, 2022-2031
Figure 52: Middle East & Africa America Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031
Figure 53: Middle East & Africa Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031
Figure 54: Middle East & Africa Drug Eluting Balloon Market Attractiveness Analysis, by End-user 2023-2031
Figure 55: Global Drug Eluting Balloon Market Share Analysis, by Company (2022)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Drug Eluting Balloon Market
